What adverse reactions happened during this study?
The most common adverse reaction was diarrhea.
The table below shows the adverse reactions that happened in 5 or more of
participants during the study. There were other adverse reactions, but these
happened in fewer participants.
Most common adverse reactions
Parts 1 and 2
(out of 27
Adverse reaction participants)
Diarrhea 44.4% (12)
Fatigue 22.2% (6)
Nausea 22.2% (6)
High blood sugar 18.5% (5)
A rash with flat and bumpy parts on the skin 18.5% (5)
How has this study helped patients and
researchers?
This study helped researchers learn more about the safety of capivasertib when
given with some of the existing medicines in men with prostate cancer that had
spread to other parts of the body.
Researchers look at the results of many studies to decide which treatments work
best and are safest. This summary shows only the main results from this one
study. Other studies may provide new information or different results.
Further clinical studies with capivasertib are planned.
11 | Clinical Study Results